Helen E. Jack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Helen E. Jack has a total of 211 co-authors. Here are the top co-authors by number of shared publications:
Jessica F. Magidson
Department of Psychology, University of Maryland, College Park, USA
5 shared publications- Melanie Abas
Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
5 shared publications - Walter Mangezi
Department of Mental Health Harare Harare Province University of Zimbabwe
5 shared publications - Bronwyn Myers
Curtin University
4 shared publications Debra Machando
University of Zimbabwe
4 shared publications- Jessica F. Magidson
Department of Psychology, University of Maryland, College Park, College Park, MD, United States
4 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 63, 101631
US jail and prison institutional research policies: a lever in access to research for incarcerated people
- 11 September 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 63, 101631
Open AccessUS jail and prison institutional research policies: a lever in access to research for incarcerated people
- Open Access
- 22 January 2026
- Published by Cambridge University Press (CUP) in Cambridge Prisms: Global Mental Health
- Vol. 13, 1-33
Recognition of depression by nurses in primary healthcare in Zimbabwe: Cross-sectional study
Depression is underrecognized in primary care, which is a barrier to treatment. For the last decade, Zimbabwe has invested in increasing access to depression treatment within primary healthcare. This study describes depression recognition by nurses and referral to treatment in four primary care clinics in Zimbabwe. Research staff screened 200 patients after they attended a primary care visit at a study clinic. They assessed depression using the PHQ-9 and assessed depression and/or anxiety using the Shona Symptoms Questionnaire (SSQ-14). Medical records were examined for depression and/or anxiety diagnoses. Positive depression and anxiety screens were compared with nurse documentation. 69.5% of participants were women and 56.5% were living with HIV. 6.0% had a PHQ-9 score ≥11, indicative of depression, and 22.0% had an SSQ score ≥9, indicative of depression and/or anxiety. None of the patients who screened positive for probable depression and/or anxiety were recognized by nurses. Nurses who saw the patients in the sample were surveyed. Most had not received formal training on mental health in primary care (mhGAP) prior to patient data collection. Despite efforts to expand depression treatment in Zimbabwe, individuals with probable depression were unrecognized by nurses, though nurses offered some care for other mental health conditions.
- 22 January 2026
- Published by Cambridge University Press (CUP) in Cambridge Prisms: Global Mental Health
- Vol. 13, 1-33
Open AccessRecognition of depression by nurses in primary healthcare in Zimbabwe: Cross-sectional study
Depression is underrecognized in primary care, which is a barrier to treatment. For the last decade, Zimbabwe has invested in increasing access to depression treatment within primary healthcare. This study describes depression recognition by nurses and referral to treatment in four primary care clinics in Zimbabwe. Research staff screened 200 patients after they attended a primary care visit at a study clinic. They assessed depression using the PHQ-9 and assessed depression and/or anxiety using the Shona Symptoms Questionnaire (SSQ-14). Medical records were examined for depression and/or anxiety diagnoses. Positive depression and anxiety screens were compared with nurse documentation. 69.5% of participants were women and 56.5% were living with HIV. 6.0% had a PHQ-9 score ≥11, indicative of depression, and 22.0% had an SSQ score ≥9, indicative of depression and/or anxiety. None of the patients who screened positive for probable depression and/or anxiety were recognized by nurses. Nurses who saw the patients in the sample were surveyed. Most had not received formal training on mental health in primary care (mhGAP) prior to patient data collection. Despite efforts to expand depression treatment in Zimbabwe, individuals with probable depression were unrecognized by nurses, though nurses offered some care for other mental health conditions.
- 15 September 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 407-409
Executive Summary: State-of-the-Art Review: The Intersection of Infectious Diseases and Carceral Medicine
- 15 September 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , 407-409
Executive Summary: State-of-the-Art Review: The Intersection of Infectious Diseases and Carceral Medicine
- 15 September 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , e42-e51
State-of-the-Art Review: The Intersection of Infectious Diseases and Carceral Medicine
Mass incarceration is a national epidemic; all clinicians will encounter persons currently incarcerated or with a history of criminal-legal involvement. Infections are highly prevalent in these populations. This review will support clinicians to provide evidence-based infectious diseases treatment with explicit recognition of the interpersonal and structural intricacies in carceral care. Following a criminal-legal system primer, clinicians will have a finer understanding of the psychosocial complexities involved in building provider–patient relationships with those impacted by this system. By recognizing that care delivery can be subject to a potential conflict of interest in supporting both the health interests of persons incarcerated while respecting the unique carceral institution regulations in place to protect carceral staff, clinicians will navigate the concept of “dual loyalty.” With this, in conjunction with supporting patient autonomy in treatment decisions and providing infection-prevention counseling and treatment, clinicians can create a therapeutic patient alliance and reduce health disparities.
- 15 September 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , e42-e51
State-of-the-Art Review: The Intersection of Infectious Diseases and Carceral Medicine
Mass incarceration is a national epidemic; all clinicians will encounter persons currently incarcerated or with a history of criminal-legal involvement. Infections are highly prevalent in these populations. This review will support clinicians to provide evidence-based infectious diseases treatment with explicit recognition of the interpersonal and structural intricacies in carceral care. Following a criminal-legal system primer, clinicians will have a finer understanding of the psychosocial complexities involved in building provider–patient relationships with those impacted by this system. By recognizing that care delivery can be subject to a potential conflict of interest in supporting both the health interests of persons incarcerated while respecting the unique carceral institution regulations in place to protect carceral staff, clinicians will navigate the concept of “dual loyalty.” With this, in conjunction with supporting patient autonomy in treatment decisions and providing infection-prevention counseling and treatment, clinicians can create a therapeutic patient alliance and reduce health disparities.
- 15 April 2025
- Published by Elsevier in The Lancet Psychiatry
- Vol. 12 (8) , 611-618
Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panel
- 15 April 2025
- Published by Elsevier in The Lancet Psychiatry
- Vol. 12 (8) , 611-618
Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panel
- 6 March 2025
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 100 (7) , 790-795
Substance Use and Pain Curriculum Innovation: Establishing a Student-Faculty Partnership for Curricular Change
Problem: The opioid overdose crisis had progressed broadly in the United States, with a 21% increase from 2016 to 2017, and specifically in Massachusetts, with a peak rate of 1,374 deaths in 2016. In 2016, students and faculty at Harvard Medical School (HMS) established the Substance Use and Pain Curriculum Committee (SUPCC) to expand substance use and pain education. However, faculty capacity, financial resources, and administrative support were insufficient to implement changes across all phases of the medical school curriculum. Approach: The HMS SUPCC restructured in 2021 to put students at the forefront of curricular development. This restructuring was done through 3 main innovations: (1) establishment of a student-centered committee structure, ensuring that curricular changes are centered on student interests and needs; (2) student-led curricular development and implementation, reducing faculty workload; and (3) focus on clinically relevant teaching and opportunities to practice learned skill sets. Outcomes: This student-centered structure facilitated the expansion of the addiction and pain medicine curriculum to more than 30 hours of teaching by 2024. Examples of student-driven initiatives include development of an opioid use disorder management practicum equivalent to the Drug Enforcement Agency X-waiver, increased medical student access to naloxone through a hospital partnership, and integration of case-based opioid use disorder and pain medicine didactics into the clerkship year. Next Steps: Although this work has established a longitudinal curriculum across all medical training stages, more must be done in clerkship rotations to help students apply their substance use and pain education in the clinical setting. The HMS SUPCC is working to incorporate teaching on nonopioid substances, such as alcohol, cannabis, and ketamine; provide longitudinal clinical experiences so students learn to care for patients with substance use disorder and chronic pain from short-term intervention to long-term recovery; and develop surveys to quantitatively and qualitatively measure curriculum outcomes.
- 6 March 2025
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 100 (7) , 790-795
Substance Use and Pain Curriculum Innovation: Establishing a Student-Faculty Partnership for Curricular Change
Problem: The opioid overdose crisis had progressed broadly in the United States, with a 21% increase from 2016 to 2017, and specifically in Massachusetts, with a peak rate of 1,374 deaths in 2016. In 2016, students and faculty at Harvard Medical School (HMS) established the Substance Use and Pain Curriculum Committee (SUPCC) to expand substance use and pain education. However, faculty capacity, financial resources, and administrative support were insufficient to implement changes across all phases of the medical school curriculum. Approach: The HMS SUPCC restructured in 2021 to put students at the forefront of curricular development. This restructuring was done through 3 main innovations: (1) establishment of a student-centered committee structure, ensuring that curricular changes are centered on student interests and needs; (2) student-led curricular development and implementation, reducing faculty workload; and (3) focus on clinically relevant teaching and opportunities to practice learned skill sets. Outcomes: This student-centered structure facilitated the expansion of the addiction and pain medicine curriculum to more than 30 hours of teaching by 2024. Examples of student-driven initiatives include development of an opioid use disorder management practicum equivalent to the Drug Enforcement Agency X-waiver, increased medical student access to naloxone through a hospital partnership, and integration of case-based opioid use disorder and pain medicine didactics into the clerkship year. Next Steps: Although this work has established a longitudinal curriculum across all medical training stages, more must be done in clerkship rotations to help students apply their substance use and pain education in the clinical setting. The HMS SUPCC is working to incorporate teaching on nonopioid substances, such as alcohol, cannabis, and ketamine; provide longitudinal clinical experiences so students learn to care for patients with substance use disorder and chronic pain from short-term intervention to long-term recovery; and develop surveys to quantitatively and qualitatively measure curriculum outcomes.
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study
Background and aims: Primary care systems often screen for unhealthy alcohol use with brief self‐report tools such as the 3‐item Alcohol Use Disorders Identification Test for consumption (AUDIT‐C). There is little research examining whether change in alcohol use measured on the AUDIT‐C captures meaningful change in outcomes affected by alcohol use. This study aimed to measure the association between change in AUDIT‐C and change in all‐cause hospitalization risk, measured in the year after each AUDIT‐C.Design: Retrospective cohort study.Setting: Health system in the state of Washington, USA, that conducts annual screening with the AUDIT‐C in outpatient care.Participants: Adults (n = 165 101) who had completed at least two AUDIT‐Cs 11–24 months apart (2016–2020).Measurements: AUDIT‐C scores were grouped into five risk categories reflecting no drinking (0), drinking without unhealthy alcohol use [1–2 (female)/1–3 (male)] and unhealthy alcohol use with moderate risk [3–6 (female)/4–6 (male)], high risk (7–8), and very high risk (9–12). Changes in AUDIT‐C were based on the number of category levels that changed (0–4). Hospitalizations were binary, reflecting one or more hospitalizations in the 365 days after each AUDIT‐C, identified from insurance claims.Findings: Of 165 101 eligible patients, 5.7% and 6.1% were hospitalized the year after the first and second AUDIT‐C, respectively. Decreases in AUDIT‐C risk category of 1 or ≥2 levels were associated with statistically significant decreases in risk of hospitalization, compared with the change in hospitalization risk for those with no change in AUDIT‐C [1‐level decrease: ratio of adjusted risk ratios (aRR) = 0.92, 95% confidence interval (CI) = 0.86–0.99; ≥2‐level decrease: ratio of aRR = 0.68, 95% CI = 0.58–0.81]. Increases in AUDIT‐C risk category of 1 or ≥2 levels were not associated with statistically significant differences in risk of hospitalization, compared with those with no change in AUDIT‐C.Conclusions: A decrease in AUDIT‐C score risk category is associated with a decreased risk of both all‐cause hospitalizations and hospitalizations with conditions directly or potentially attributable to alcohol. An increase in AUDIT‐C score does not appear to be associated with a change in risk of hospitalization in the following year.
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study
Background and aims: Primary care systems often screen for unhealthy alcohol use with brief self‐report tools such as the 3‐item Alcohol Use Disorders Identification Test for consumption (AUDIT‐C). There is little research examining whether change in alcohol use measured on the AUDIT‐C captures meaningful change in outcomes affected by alcohol use. This study aimed to measure the association between change in AUDIT‐C and change in all‐cause hospitalization risk, measured in the year after each AUDIT‐C.Design: Retrospective cohort study.Setting: Health system in the state of Washington, USA, that conducts annual screening with the AUDIT‐C in outpatient care.Participants: Adults (n = 165 101) who had completed at least two AUDIT‐Cs 11–24 months apart (2016–2020).Measurements: AUDIT‐C scores were grouped into five risk categories reflecting no drinking (0), drinking without unhealthy alcohol use [1–2 (female)/1–3 (male)] and unhealthy alcohol use with moderate risk [3–6 (female)/4–6 (male)], high risk (7–8), and very high risk (9–12). Changes in AUDIT‐C were based on the number of category levels that changed (0–4). Hospitalizations were binary, reflecting one or more hospitalizations in the 365 days after each AUDIT‐C, identified from insurance claims.Findings: Of 165 101 eligible patients, 5.7% and 6.1% were hospitalized the year after the first and second AUDIT‐C, respectively. Decreases in AUDIT‐C risk category of 1 or ≥2 levels were associated with statistically significant decreases in risk of hospitalization, compared with the change in hospitalization risk for those with no change in AUDIT‐C [1‐level decrease: ratio of adjusted risk ratios (aRR) = 0.92, 95% confidence interval (CI) = 0.86–0.99; ≥2‐level decrease: ratio of aRR = 0.68, 95% CI = 0.58–0.81]. Increases in AUDIT‐C risk category of 1 or ≥2 levels were not associated with statistically significant differences in risk of hospitalization, compared with those with no change in AUDIT‐C.Conclusions: A decrease in AUDIT‐C score risk category is associated with a decreased risk of both all‐cause hospitalizations and hospitalizations with conditions directly or potentially attributable to alcohol. An increase in AUDIT‐C score does not appear to be associated with a change in risk of hospitalization in the following year.
- 31 October 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 134, 104627
Framework for opioid use disorder screening and diagnosis in carceral settings
- 31 October 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 134, 104627
Framework for opioid use disorder screening and diagnosis in carceral settings
- Open Access
- 14 August 2024
- Published by Elsevier in JACEP Open
- Vol. 5 (4) , e13253
Peer support for patients with opioid use disorder in the emergency department: A narrative review
- 14 August 2024
- Published by Elsevier in JACEP Open
- Vol. 5 (4) , e13253
Open AccessPeer support for patients with opioid use disorder in the emergency department: A narrative review